Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-41
SponsorAalborg University Hospital

About this trial

A low plasma level of mannose binding lectin (p-MBL) is associated with unexplained recurrent pregnancy loss (RPL), but it is not investigated if it is associated with unexplained reproductive failure in general, including recurrent implantation failure (RIF) after assisted reproductive technology (ART) (including IVF, ICSI and FET), recurrent pregnancy loss (RPL) after spontaneous conception, and RPL after ART.

Eligibility criteria

Qualifiers

3 consecutive pregnancy losses after spontaneous conception

3 consecutive pregnancy losses after assisted reproductive technology treatment (ART) including IVF, ICSI and FET

3 failed embryo transfers characterized by no achieved pregnancy (after 3 cycles with minimum 1 embryo transfer of a good-quality embryo in each cycle.)

Disqualifiers

Age <18 or >45 years

AMH <4.0 pmol/l unless donor egg in previous cycles

Significant uterine malformation

Known endometrial pathologies including intrauterine endometriosis, adenomyosis, hyperplasia or polyps

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

500 Participants
are grouped into 3 trial groups

Sponsors and collaborators